1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ADDEX THERAPEUTICS LTD - ADR
Addex Therapeutics Ltd - ADR
XNAS: ADXN
Download real time
3.220.04(1.26%)
73.10% Fall from 52W High
4,512
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Addex Therapeutics Ltd (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Addex Therapeutics Ltd (ADR) quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue Addex Therapeutics Ltd (ADR) Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Quarterly Net Profit Addex Therapeutics Ltd (ADR) Jun-2026 Quarterly Net Profit is $-2 Million which is growth of 5.2% YoY.

Addex Therapeutics Ltd - ADR, Earnings Report - Quarterly Results, standalone, All financials are in CHF Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
00.10.10.20.20.30.6
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
-0.70.50.80.70.70.60.50.7112.833.2
Operating Profit
-0.7-0.5-0.8-0.7-0.7-0.6-0.5-0.6-0.9-0.8-2.7-2.7-2.6
⌄
000
Profit Before Tax
-1.7-1.7-1.8-1.6-2-1.5-1.2-1.5-1.5-0.7-2.9-2.6-2.7
Tax
-
⌄
-1.7-1.7-1.8-1.6-1.8-1.5-1.2-1.512.9-3.1-2.9-2.6-2.7
Diluted NI Avail to Com Stockholders Ann.
-1.7-1.7-1.8-1.6-1.8-1.5-1.2-1.512.9-3.1-2.9-2.6-2.7
Basic EPS
-1.2-1.2-1.2-1.2-2.4-1.2-1.2-2.415.6-3.6-3.6-3.6-4.8
Diluted EPS After ExtraOrdinary
--1.2-1.2-1.2-2.4-1.2-1.2-2.4-1.2-1.3-3.4-3.6-4.6
Number Of Shares End
1110.90.80.80.80.80.80.80.70.60.6
Net Income Continuing Discontinued Operations
-1.7-1.7-1.8-1.6-1.8-1.5-1.2-1.512.9-3.1-2.9-2.6-2.7
Normalized Income
-1.7-1.7-1.8-1.6-2-1.5-1.2-1.5-1.4-0.8-2.7-2.6-2.5
Interest Income
---0000
Interest
-0
Net Interest Income
-000
EBIT
-1.7-1.7-1.8-1.6-2-1.5-1.2-1.5-1.5-0.7-2.9-2.6-2.7
EBITDA
-1.7-1.7-1.8-1.6-2-1.5-1.2-1.5-1.3-0.7-2.8-2.5-2.6
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
-000.10.10.10.10.10.1
Profit From Continuing Operations
-1.7-1.7-1.8-1.6-1.8-1.5-1.2-1.512.9-3.1-2.9-2.6-2.7
Normalized EBITDA
--1.7-1.8-1.6-2-1.5-1.2-1.4-1.3-0.7-2.6-2.6-2.5
*All financials are in CHF Million and price data in USD
Add metric to table
Search...

Addex Therapeutics Ltd (ADR) competitor comparison and performance snapshot within industry

Addex Therapeutics Ltd (ADR) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Annual Revenue Addex Therapeutics Ltd (ADR) Dec-2025 Annual Revenue is $0 Million which is growth of -92.6% YoY.

  • NEGATIVE

    Annual Net Profit Addex Therapeutics Ltd (ADR) Dec-2025 Annual Net Profit is $-7 Million which is growth of -195.4% YoY.

Addex Therapeutics Ltd - ADR, Earnings Report - Annual Results, standalone, All financials are in CHF Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
 00.41.61.42.93.62.86--
Cost Of Rev. Ann.
-
-
 -----------
Gross Profit Ann.
-
-
 -----------
Operating Exp. Ann.
-49.6%
-29.3%
1.32.83.211.921.918.415.917.47.53.23.12.6
Operating Profit Ann.
-
-
-2.6-2.8-2.8-10.3-20.5-15.5-12.2-14.6-1.4-3.2-3.1-2.6
⌄
-
-
-000-0-0.1-0-0.1-0.2-0.1-0-0.2
Other Exp. Ann.
-
-
 -4-2.2-0.3-0.30.2-0.6-0.1---1.4
PBT Ann.
-
-
-6.9-6.8-4.9-10.6-20.8-15.4-12.9-14.8-1.6-3.3-3.2-4.2
Tax Ann.
-
-
 -
⌄
-
-
-6.9-6.77.1-10.6-20.8-15.4-12.9-14.8-1.6-3.3-3.2-4.2
Diluted NI Avail to Com Stockholders Ann.
-
-
-6.9-6.77.1-10.6-20.8-15.4-12.9-14.8-1.6-3.3-3.2-4.2
EPS Ann.
-
-
 -7.28.4-16.8-55.2-54-57.6-67.2-8.4-30-33.6-46.8
Diluted EPS Ann.
-
-
 -7.28.4-16.8-55.2-54-57.6-67.2-8.4-30-33.6-46.8
Number Of Shares End
26%
38%
 10.80.70.50.30.20.226.413.411.611
Total Exp. Ann.
-49.6%
-29.3%
 2.83.211.921.918.415.917.47.53.23.12.6
Net Income Continuing Discontinued Operations Ann.
-
-
-6.9-6.77.1-10.6-20.8-15.4-12.9-14.8-1.6-3.3-3.2-4.2
Normalized Income Ann.
-
-
-6.9-6.8-4.9-10.2-20.5-15.6-12.3-14.7-1.6-3.3-3.2-2.8
Interest Income Ann.
-
-
 00.10000--
Interest Ann.
-
-
 00.10.10.10.10.20.100.2
EBITDA Ann.
-
-
-6.8-6.8-4.7-10.2-20.4-14.9-12.4-14.3-1.4-3.2-3.1-4
Reconciled Cost Of Rev. Ann.
-
-
 -----------
Reconciled Depr. Ann.
-
-
 00.30.30.30.40.40.3000
Profit From Continuing Operations Ann.
-
-
-6.9-6.77.1-10.6-20.8-15.4-12.9-14.8-1.6-3.3-3.2-4.2
Normalized EBITDA Ann.
-
-
 -6.8-4.7-9.9-20.2-15.2-11.8-14.2-1.4-3.2-3.1-2.6
*All financials are in CHF Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
-12.5%
2Y CAGR
-51.5%
3Y CAGR
-49.6%
5Y CAGR
-29.3%
7Y CAGR
-13.1%
10Y CAGR
0.7%
Operating Expenses Annual Cr is falling slower than historical averages.

Addex Therapeutics Ltd (ADR) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Addex Therapeutics Ltd (ADR) Dec-2025 Total Shareholders Fund is $5 Million which is growth of -50.7% YoY.

  • NEGATIVE

    Total Assets Addex Therapeutics Ltd (ADR) Dec-2025 Total Assets is $6 Million which is growth of -40.4% YoY.

Addex Therapeutics Ltd - ADR, Balance Sheet, standalone, All financials are in CHF Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-8.3%
-20.5%
6.410.74.68.322.520.23342.23.11.72.9
⌄
-22.2%
-22.2%
1.613.53.45.65.67.531.71.51.2
⌄
-0.7%
-19.9%
4.89.71.24.916.914.625.539.21.30.21.7
Total Capitalization Ann.
-0.7%
-19.9%
4.89.71.24.916.914.625.539.21.30.21.7
Tangible Assets Ann.
-0.7%
-19.9%
4.89.71.24.916.914.625.539.21.30.21.7
Working Capital Ann.
-52.3%
-49.9%
0.52.71.34.617.815.926.739.81.60.41.8
Invested Capital Ann.
-0.7%
-19.9%
4.89.71.24.916.914.625.539.21.30.21.7
Tangible Book Value Ann.
-0.7%
-19.9%
4.89.71.24.916.914.625.539.21.30.21.7
Borrowings Ann.
-
-
000.30.40.50.60.6----
Net Debt Ann.
-
-
-----------
Share Issued Ann.
23.8%
46.1%
218.7184.4184.4115.449.332.932.928.615.411.611
Number Of Shares End
26%
38%
10.80.70.50.30.20.226.413.411.611
*All financials are in CHF Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-40.2%
2Y CAGR
18%
3Y CAGR
-8.3%
5Y CAGR
-20.5%
7Y CAGR
-23.6%
10Y CAGR
8.2%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
50%
2Y CAGR
-35.7%
3Y CAGR
-28.6%
5Y CAGR
-19.7%
7Y CAGR
-8.9%
10Y CAGR
1.8%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-50.5%
2Y CAGR
100%
3Y CAGR
-0.7%
5Y CAGR
-19.9%
7Y CAGR
-25.9%
10Y CAGR
10.9%
Total ShareHolders Funds Annual is falling faster than historical averages.

Addex Therapeutics Ltd (ADR) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Addex Therapeutics Ltd (ADR) Book Value Per Share is $8 which is growth of -28.9% YoY.

  • POSITIVE

    ROE Addex Therapeutics Ltd (ADR) ROE is -93% which is growth of 223.6% YoY.

Addex Therapeutics Ltd - ADR, Ratios, standalone, All financials are in CHF Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-78.96%92.11%-163.36%-134.99%-71.87%-48.33%-39.29%-7.27%-138.24%-137.75%-122.06%
ROE Ann. %
-
-
-93.16%130.39%-348.48%-190.48%-97.35%-64.08%-45.64%-8.11%-420.26%-334.54%-209.69%
ROIC %
-
-
-34-11.6-99.4-53.6-28.2-13.6-14----
OPM Ann. %
-
-
-9,391.39%-681.82%-637.43%-1,442.61%-531.71%-338.88%-528.60%-23.57%---
Inventory Turnover Ratio Ann.
-
-
-----------
Asset Turnover Ann. %
0%
0%
0.10.30.10.10.10.10.3---
Working Capital Turnover Ann.
-30.7%
-12.9%
0.10.21.20.30.20.20.10.2--
Quick Ratio Ann.
-15.3%
-23.1%
1.44.21.42.355.25.61821.32.7
Current Ratio Ann.
-16.4%
-23.7%
1.44.41.52.45.35.45.718.12.11.32.7
Interest Coverage Ratio Ann.
-
-
-2,825.4-1,383.1-487.6-424.5-242.6-184-114-6.5-71.3-453.9-26.6
LT Debt To Equity Ann.
-
-
00.10000----
*All financials are in CHF Million and price data in USD
Add metric to table
Search...
Current Ratio Ann.
1Y CHG
-68.2%
2Y CAGR
-3.4%
3Y CAGR
-16.4%
5Y CAGR
-23.7%
7Y CAGR
-30.6%
10Y CAGR
-6.4%
Current Ratio Annual is falling faster than historical averages.

Addex Therapeutics Ltd (ADR) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity Addex Therapeutics Ltd (ADR) Dec-2025 Cash From Operating Activity is $-2 Million which is growth of 59.6% YoY.

  • NEGATIVE

    Net Cash Flow Addex Therapeutics Ltd (ADR) Dec-2025 Net Cash Flow is $-2 Million which is growth of -167.5% YoY.

Addex Therapeutics Ltd - ADR, Cash Flow, standalone, All financials are in CHF Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
-2.2-5.4-8-16.4-14.7-12.2-9.51.8-2.1-2.7-2.6
⌄
-
-
-0.74.7-0-0-0.1-0-0.10.4
⌄
-27.1%
64.4%
1.20.15.33.116.40.1-0.537.43.41.52.9
Cash Plus Cash Eqv. End Of Year Ann.
-38.9%
-38.8%
1.63.33.9720.518.731.541.72.61.42.6
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-1.7-0.6-2.7-13.31.7-12.2-1039.11.2-1.20.7
Cash Plus Cash Eqv. Begin Of Year Ann.
-45.6%
-36.3%
3.33.9720.518.731.541.72.61.42.62
Income Tax Paid Supplemental Data Ann.
-
-
-----------
Interest Paid Supplemental Data Ann.
-
-
-----------
Capex Ann.
-
-
--0-0-0.1-0-0-0-
Issuance Of Capital Stock Ann.
-11%
11.4%
1.20.22.41.7140.7040.53.41.53.2
Issuance Of Debt Ann.
-
-
-----------
Repayment Of Debt Ann.
-
-
-0-0.1-0.3-0.3-0.3-0.4-0.3----
Repurchase Of Capital Stock Ann.
-
-
-0-0--0.4------
Free Cash Flow Ann.
-
-
-2.2-5.4-8-16.4-14.7-12.2-9.51.7-2.1-2.7-2.6
*All financials are in CHF Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
1100%
2Y CAGR
-52.4%
3Y CAGR
-27.1%
5Y CAGR
64.4%
7Y CAGR
-38.8%
10Y CAGR
-8.4%
Cash from Financing Annual Activity growth is higher than historical averages.
×